Back
NovaBay Pharmaceuticals, Inc. Vs. Builders FirstSource, Inc. Industry Stock Comparison
Buy
85
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$19.26
Seasonality Move:
5.22%
Buy
67
BLDR
Builders FirstSource, Inc.
Last Price:
$124.75
Seasonality Move:
14.1%
Buy
85
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $19.16. The Score for NBY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
67
Builders FirstSource, Inc. (BLDR)
is a Buy
Is Builders FirstSource, Inc. a Buy, Sell or Hold?
-
The current Builders FirstSource, Inc. [BLDR] share price is $124.66. The Score for BLDR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
BLDR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $19.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLDR Stock Price Chart
What is Builders FirstSource, Inc.'s stock price today?
-
The Builders FirstSource, Inc. share price today is $124.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLDR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.66 | Buy |
| Relative Strength Index (14 RSI): | 88.54 | Buy |
| Chaikin Money Flow: | 9056672 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 8.68) | Buy |
| Bollinger Bands (100): | (-0.14 - 4.82) | Buy |
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.27 | Buy |
| Relative Strength Index (14 RSI): | 70.25 | Buy |
| Chaikin Money Flow: | 3995063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.39 - 112.11) | Buy |
| Bollinger Bands (100): | (105.29 - 133.21) | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.76 | Buy |
| 20-day SMA: | 5.77 | Buy |
| 50-day SMA: | 2.97 | Buy |
| 200-day SMA: | 1.47 | Buy |
| 8-day EMA: | 10.07 | Buy |
| 20-day EMA: | 6.74 | Buy |
| 50-day EMA: | 4.01 | Buy |
| 200-day EMA: | 1.44 | Buy |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.78 | Buy |
| 20-day SMA: | 106.66 | Buy |
| 50-day SMA: | 107.46 | Buy |
| 200-day SMA: | 120.17 | Buy |
| 8-day EMA: | 111.03 | Buy |
| 20-day EMA: | 108.19 | Buy |
| 50-day EMA: | 110.09 | Buy |
| 200-day EMA: | 123.34 | Buy |
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Builders FirstSource, Inc. Earnings Growth & BLDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $2.05 per share.
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Builders FirstSource, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||